Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Aurinia Pharmaceuticals Inc. (AUPH)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 11/27/2018 |
GN
| Analysis: Positioning to Benefit within Abeona Therapeutics, Great Lakes Dredge & Dock, Imprimis Pharmaceuticals, Alliant Energy, Cytokinetics, and Aurinia Pharmaceuticals — Research Highlights Growth, Revenue, and Consolidated Results |
| 10/16/2018 |
GN
| New Research: Key Drivers of Growth for Haverty Furniture Companies, BLACKLINE INC, MagnaChip Semiconductor, Kinross Gold, Aurinia Pharmaceuticals, and NEXEO SOLUTIONS — Factors of Influence, Major Initiatives and Sustained Production |
| 08/17/2018 |
GN
| Investor Expectations to Drive Momentum within Natural Resource Partners LP, Insmed, MagnaChip Semiconductor, Changyou, Pain Therapeutics, and Aurinia Pharmaceuticals — Discovering Underlying Factors of Influence |
| 06/01/2018 |
GN
| Factors of Influence in 2018, Key Indicators and Opportunity within Shinhan Financial Group, Aurinia Pharmaceuticals, Delphi Technologies, Green Plains Partners LP, Sprague Resources LP, and CRH — New Research Emphasizes Economic Growth |
| 04/09/2018 |
GN
| New Research Coverage Highlights SINOPEC Shangai Petrochemical, Aurinia Pharmaceuticals, Valeant Pharmaceuticals International, NTT DOCOMO, Southern Missouri, and KNOT Offshore Partners LP — Consolidated Revenues, Company Growth, and Expectations for 2018 |
| 11/14/2017 |
BW
| Aurinia Reports Third Quarter 2017 Financial Results and Provides Operational Highlights |
|
|